-
Frameworks for the Use of AI Within HEOR: A Targeted Literature Review and Thematic Analysis
Sep 9, 2025, 16:22 PM -
Designing Digital Healthcare Professional Surveys: A Methodological Overview
Sep 9, 2025, 16:22 PM -
Economic and Clinical Impact of Older Adult Vaccination With the Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine in Mexico
Sep 9, 2025, 16:22 PM -
Budget Impact of an Organized Cervical Cancer Screening in High-Risk Populations in France
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life Among People With Arthritis in Ireland
Sep 9, 2025, 16:22 PM -
The Life With Amyotrophic Lateral Sclerosis: Socioeconomic Impact of the Disease on Patients and Their Caregivers in the Czech Republic
Sep 9, 2025, 16:22 PM -
What Affects Quality of Life Most in Oral Cancer Therapy? A Pilot Study of Adherence and Side Effects
Sep 9, 2025, 16:22 PM -
Beyond Leave-One-Out: A Ranked Leave-k-Out Method for Detecting Influential Studies
Sep 9, 2025, 16:22 PM -
Spillover Effects on Informal and Family Caregivers' Utility: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Predicting Italian EQ-5D-3L Health State Utilities From UK Values: Validation of a Nonlinear Utility Adjustment Model Using Real-World Evidence
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Survival of Patients With HR+/HER2-negative Metastatic Breast Cancer After Treatment With CDK4/6-Inhibitors in Finland
Sep 9, 2025, 16:22 PM -
Health Technology Assessments of Oncology Orphan and Advanced Therapies: The Case for Incorporating Real-World Evidence Patient-Reported Outcomes and Indirect Treatment Comparisons Into Joint Clinical Assessment Submissions
Sep 9, 2025, 16:22 PM -
Health Utility and Indirect Costs of Neuromuscular Disease Through a Patient-Centered Lens: A National Patient and Caregiver Survey
Sep 9, 2025, 16:22 PM -
Effectiveness of HPV Vaccination Across Europe: A Comparative Analysis
Sep 9, 2025, 16:22 PM -
Analysis of ATC Equivalent Group and Therapeutic Reference Code Distributions Based on Drug Price and Reimbursement Lists in Türkiye Between 2020 and 2025
Sep 9, 2025, 16:22 PM -
Evaluation of Health-Related Quality of Life (HRQoL) Among Patients Treated With Lifileucel After Progression on Immune Checkpoint Inhibitors (ICIs) and Targeted Therapies: Analyses From the C-144-01 Trial
Sep 9, 2025, 16:22 PM -
Examination of Attitudes Towards Vaccinations Among the Hungarian Population
Sep 9, 2025, 16:22 PM -
Treatment Discontinuation in Idiopathic Pulmonary Fibrosis: A Systematic Review of Antifibrotic Drug Use and Tolerability
Sep 9, 2025, 16:22 PM -
Do Short-Term Outcome-Based Payments for Treatments Provide the Same Incremental Net Benefit As List Price Discounts?
Sep 9, 2025, 16:22 PM -
Decoding Atorvastatin-Induced Arthritis: A Systems Pharmacology Approach Integrating Pharmacovigilance, Bioinformatics, and Pathway Enrichment
Sep 9, 2025, 16:22 PM
